SavedAdd your journal

Journals / Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi / 2019 / Cilt: 24 - Sayı: 2

A Case of Brucellosis Associated Hemophagocytic Lymphohistiocytosis: The Importance of Epidemiological History

Bruselloz İlişkili Bir Hemofagositik Lenfohistiyositoz Olgusu: Epidemiyolojik Öykünün Önemi

Mehmet Cihat SİFİL
Sevgi YAŞAR-DURMUŞ
Fatma NUR ÖZ
Gönül TANIR
Pages
148–151
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The patient responded dramatically to empirical antibrucellosis theraphy.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Brucellosis is a zoonotic disease, which is an important public health problem in Turkey.
📊
Key Findings & Data:In children, it often causes osteoarticular symptoms, but the disease may effect other systems, as well.
💡
Conclusion & Impact:The patient responded dramatically to empirical antibrucellosis theraphy.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Brucellosis is a zoonotic disease, which is an important public health problem in Turkey. In children, it often causes osteoarticular symptoms, but the disease may effect other systems, as well. The most common hematological signs of brusellosis are anemia, thrombocytopenia and leukopenia. Hemophagocytic lymphohistiocytosis is a rare, life-threatening complication of brucellosis. The aim of this study was to report a case presented with hemophagocytic lymphohistiocytosis, who had epidemiological clues about brucellosis. The patient responded dramatically to empirical antibrucellosis theraphy.

Özet

Bruselloz Türkiye’de önemli bir halk sağlığı problemi olan zoonotik bir hastalıktır. Çocuklarda sıklıkla osteoartiküler bulgulara yol açsa da, hastalık diğer tüm sistemleri etkileyebilir. Brusellozun en sık hematolojik bulguları ise anemi, trombositopeni ve lökopenidir. Hemofagositik lenfohistiyositoz brusellozun hayatı tehdit edici nadir bir komplikasyonudur. Burada hemofagositik lenfohistiyositoz tablosunda başvuran, Brucella’ya yönelik epidemiyolojik ipuçları olan, başlanılan ampirik antibruselloz tedaviye dramatik yanıt veren bir hastayı sunduk.

🔖

Cite This Article

SİFİL, M. C., YAŞAR-DURMUŞ, S., ÖZ, F. N., TANIR, G. (2019). A Case of Brucellosis Associated Hemophagocytic Lymphohistiocytosis: The Importance of Epidemiological History. Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi, Cilt: 24 - Sayı: 2, 148–151. https://ajindex.com/articles/224353

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Young EJ. Brucella species (Brucellosis). In: Long SS, Pickering LK, Prober CG (eds). Principles and Practice of Pediatric Infectious Diseases. Pennsylvania: Churchill Livingstone, 2012;4:876-80.
  2. Buzgan T, Karahocagil MK, Irmak H, Baran AI, Karsen H, Evirgen O, et al. Clinical manifestations and complications in 1028 cases of brucellosis: A retrospective evaluation and review of the literature. Int J Infect Dis 2010;14:469-78.
  3. Karaman K, Akbayram S, Bayhan GI, Dogan M, Parlak M, Akbayram HT, et al. Hematologic findings in children with brucellosis: Experiences of 622 patients in eastern Turkey. J Pediatr Hematol Oncol 2016;38:463-6.
  4. Gupta S, Weitzman S. Primary and secondary hemophagocytic lymphohistiocytosis: clinical features, pathogenesis and therapy. Expert Rev Clin Immunol 2010;6:137-54. George MR. Hemophagocytic lymphohistiocytosis: review of etiologies and management. J Blood Med 2014;5:69-86.
  5. Sari I, Altuntas F, Hacioglu S, Kocyigit I, Sevinc A, Sacar S, et al. A multicenter retrospective study defining the clinical and hematological manifestations of brucellosis and pancytopenia in a large series: hematological malignancies, the unusual cause of pancytopenia in patients with brucellosis. Am J Hematol 2008;83:334-9.
  6. Citak EC, Citak FE, Tanyeri B, Arman D. Hematologic manifestations of brucellosisin children: 5 years experience of an anatolian center. J Pediatr Hematol Oncol 2010;32:137- 40. Cascio A, Pernice LM, Barberi G, Delfino D, Biondo C, Beninati C, et al. Secondary hemophagocytic lymphohistiocytosis in zoonoses. A systematic review. Eur Rev Med Pharmacol Sci 2012;16:1324-37. Fisman DN. Hemophagocytic syndromes and infection. Emerg Infect Dis 2000;6:601-8.
  7. Janka G, Imashuku S, Elinder G, Schneider M, Henter JI. Infection- and malignancy-associated hemophagocytic syndromes. Secondary hemophagocytic lymphohistiocytosis. Hematol Oncol Clin North Am 1998;12:435-44.
  8. Rajajee S, Ashok I, Manwani N, Rajkumar J, Gowrishankar K, Subbiah E. Profile of hemophagocytic lymphohistiocytosis; efficacy of intravenous immunoglobulin therapy. Indian J Pediatr 2014;81:1337-41.